FPRX - Five Prime Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 2.78
52-Week Change 3-22.29%
S&P500 52-Week Change 310.93%
52 Week High 38.10
52 Week Low 31.75
50-Day Moving Average 33.80
200-Day Moving Average 33.97

Share Statistics

Avg Vol (3 month) 3352.45k
Avg Vol (10 day) 3421.1k
Shares Outstanding 536.64M
Float 25.08M
% Held by Insiders 13.06%
% Held by Institutions 173.55%
Shares Short (May 14, 2020) 41.33M
Short Ratio (May 14, 2020) 44.11
Short % of Float (May 14, 2020) 44.76%
Short % of Shares Outstanding (May 14, 2020) 43.63%
Shares Short (prior month Apr 14, 2020) 41.39M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Mar 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-657.89%

Management Effectiveness

Return on Assets (ttm)-28.44%
Return on Equity (ttm)-66.11%

Income Statement

Revenue (ttm)17.94M
Revenue Per Share (ttm)0.51
Quarterly Revenue Growth (yoy)57.40%
Gross Profit (ttm)-92.98M
EBITDA -112.76M
Net Income Avi to Common (ttm)-121.93M
Diluted EPS (ttm)-3.47
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)141.13M
Total Cash Per Share (mrq)3.99
Total Debt (mrq)48.63M
Total Debt/Equity (mrq)36.14
Current Ratio (mrq)7.82
Book Value Per Share (mrq)3.95

Cash Flow Statement

Operating Cash Flow (ttm)-96.26M
Levered Free Cash Flow (ttm)-47.85M